Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | Director | November 03, 2025 | November 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 03, 2025 · Filed November 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,226 |
Reported balance
After 2025-11-03 transaction · row 1
1 source rowRow 1 · 2025-11-03 · Grant · Acquired 3,036 · Balance 25,226 F1: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2025 Filed Nov 4, 2025 22:01 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 3,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001216815-25-000005 · wk-form4_1762293708.xml · nonDerivative · entry 1 Whims James · CIK 0001216815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,226 F1 · shares: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:57 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,864 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-120846 · ownership.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,190 F1 · shares: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 1, 2025, or for a Director not standing for re-election, the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| November 01, 2023 Filed Nov 2, 2023 23:28 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054234 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,326 F1 · shares: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 1, 2024, or for a Director not standing for re-election, the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 22:01 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055622 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,998 F1 · shares: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 1, 2023, or for a Director not standing for re-election, the date of the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:26 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,900 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-21-068554 · doc4.xml · derivative · entry 3 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,900 shares Expires 2023-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-twelfth of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2016 date of grant, until fully vested on October 28, 2017. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:26 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 8,498 | $283.39 | $2,408,248.22 |
DisclosureSEC source: 0001209191-21-068554 · doc4.xml · nonDerivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,837 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:26 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,900 | $52.57 | $152,453.00 |
DisclosureSEC source: 0001209191-21-068554 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 15:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,302 | $0.00 Strike: $89.29 | $0.00 |
DisclosureSEC source: 0001209191-21-064050 · doc4.xml · derivative · entry 4 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,302 shares Expires 2022-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-twelfth of the total number of shares subject to the option vested and became exercisable on the 23rd day of each month following the October 23, 2015 date of grant, until fully vested on October 23, 2016. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 15:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,839 | $249.88 | $709,396.54 |
DisclosureSEC source: 0001209191-21-064050 · doc4.xml · nonDerivative · entry 3 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,435 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.32 to $250, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 15:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,377 | $248.80 | $840,204.02 |
DisclosureSEC source: 0001209191-21-064050 · doc4.xml · nonDerivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,274 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.12 to $249.11, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 15:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,302 | $89.29 | $205,545.58 |
DisclosureSEC source: 0001209191-21-064050 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 23:20 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 1,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062523 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,349 F1 · shares: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 1, 2022, or for a Director not standing for re-election, the date of the Issuer's 2022 Annual Meeting of Stockholders. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,400 | $0.00 Strike: $62.11 | $0.00 |
DisclosureSEC source: 0001209191-21-009165 · doc4.xml · derivative · entry 5 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,400 shares Expires 2021-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 24th day of each month following the October 24, 2014 date of grant, until fully vested on October 24, 2015. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 567 | $119.92 | $67,994.64 |
DisclosureSEC source: 0001209191-21-009165 · doc4.xml · nonDerivative · entry 4 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,229 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,433 | $118.45 | $406,628.21 |
DisclosureSEC source: 0001209191-21-009165 · doc4.xml · nonDerivative · entry 3 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,796 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.11 to $118.62, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,400 | $117.48 | $516,912.88 |
DisclosureSEC source: 0001209191-21-009165 · doc4.xml · nonDerivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,229 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.92 to $117.89, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,400 | $62.11 | $149,052.00 |
DisclosureSEC source: 0001209191-21-009165 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:20 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056838 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,229 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · derivative · entry 6 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 113 | $88.99 | $10,055.87 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · nonDerivative · entry 5 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,762 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 250 | $87.88 | $21,970.00 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · nonDerivative · entry 4 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,875 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,031 | $86.16 | $88,831.78 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · nonDerivative · entry 3 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,125 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,106 | $85.42 | $265,313.28 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · nonDerivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,156 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 4,500 | $46.50 | $209,250.00 |
DisclosureSEC source: 0001209191-20-046470 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 204 | $67.14 | $13,696.56 |
DisclosureSEC source: 0001209191-20-028955 · doc4.xml · nonDerivative · entry 3 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,762 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 7,461 | $66.29 | $494,588.94 |
DisclosureSEC source: 0001209191-20-028955 · doc4.xml · nonDerivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,966 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.96 to $66.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 14,504 | $65.61 | $951,590.04 |
DisclosureSEC source: 0001209191-20-028955 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,427 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.96 to $65.93, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 02:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 4,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055058 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,931 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2020, or for a Director not standing for re-election, the date of the Issuer's 2020 Annual Meeting of Stockholders. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 21:06 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001209191-19-054155 · doc4.xml · derivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the last day of each month following the October 31, 2012 date of grant, until fully vested on October 31, 2013. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 21:06 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 6,000 | $23.16 | $138,960.00 |
DisclosureSEC source: 0001209191-19-054155 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 23:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 5,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058815 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,637 F1 · shares: 25% of the total number of deferred stock units shall vest and be delivered on January 31, 2019, April 30, 2019, July 31, 2019, and October 31, 2019. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:41 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $32.53 | $0.00 |
DisclosureSEC source: 0001209191-18-054432 · doc4.xml · derivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2018-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 24th day of each month following the 10/24/2011 date of grant, until fully vested on October 24, 2012. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:41 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 6,000 | $32.53 | $195,180.00 |
DisclosureSEC source: 0001209191-18-054432 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:20 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 5,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-058971 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,419 F1 · shares: 25% of the total number of deferred stock units shall vest and be delivered on January 31, 2018, April 30, 2018, July 31, 2018, and October 31, 2018. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 22:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,900 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-16-147710 · doc4.xml · derivative · entry 2 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 2,900 shares Expires 2023-10-28 F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option shall vest and become exercisable on the 28th day of each month until fully vested on October 28, 2017. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 22:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147710 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,041 F1 · shares: 25% of the total number of deferred stock units shall vest and be delivered on January 31, 2017, April 30, 2017, July 31, 2017, and October 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.